Immuron LimitedASX: IMC

Uniformed Services University to Release Topline Data

· Issued by Immuron Limited

Filed with ASX · · 5 pages · English

Summary by 6ix AI

Immuron Limited reports that the Uniformed Services University has released topline results from a clinical trial evaluating a third-party manufactured product for maintaining gut health during deployment and travel. The primary endpoint did not reach statistical significance, and Immuron identified several factors that may have influenced this outcome, including dosing timing and compliance with study procedures. The company plans to propose a clinically validated dosing schedule at an upcoming meeting with the FDA based on these findings. Immuron continues to collaborate with military research institutions on developing vaccines targeting specific pathogens.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Immuron Limited on 6ix

Earlier from Immuron

Later from Immuron

All Immuron news releases